Stenting and Angioplasty in Neurothrombectomy: Matched Analysis of Rescue Intracranial Stenting Versus Failed Thrombectomy. Issue 9 (30th June 2022)

• Record Type: Journal Article
• Authors: Mohammaden, Mahmoud H.; Haussen, Diogo C.; Al-Bayati, Alhamza R.; Hassan, Ameer; Tekle, Wondwossen; Fifi, Johanna; Matsoukas, Stavros; Kuybu, Okkes; Gross, Bradley A.; Lang, Michael J.; Narayanan, Sandra; Cortez, Gustavo M.; Hanel, Ricardo A.; Aghaebrahim, Amin; Sauvageau, Eric; Farooqui, Mudassir; Ortega-Gutierrez, Santiago; Zevallos, Cynthia; Galecio-Castillo, Milagros; Sheth, Sunil A.; Nahhas, Michael; Salazar-Marioni, Sergio; Nguyen, Thanh N.; Abdalkader, Mohamad; Klein, Piers; Hafeez, Muhammad; Kan, Peter; Tanweer, Omar; Khaldi, Ahmad; Li, Hanzhou; Jumaa, Mouhammad; Zaidi, Syed; Oliver, Marion; Salem, Mohamed M.; Burkhardt, Jan-Karl; Pukenas, Bryan A.; Alaraj, Ali; Peng, Sophia; Kumar, Rahul; Lai, Michael; Siegler, James; Nogueira, Raul G.;
• Is Part Of: Stroke. Volume 53:Issue 9(2022)
• Page Start: 2779
• Page End: 2788
• Publication Date: 2022-06-30
• Subjects: angioplasty -- middle cebrebral artery -- reperfusion -- rescue -- stenting -- thrombectomy; Cerebrovascular disease -- Periodicals; Cerebral circulation -- Periodicals; 616.81
• DOI: 10.1161/STROKEAHA.121.038248
• Languages: English
• ISSNs: 0039-2499

Abstract

Abstract : Background: Successful reperfusion is one of the strongest predictors of functional outcomes after mechanical thrombectomy (MT). Despite continuous advancements in MT technology and techniques, reperfusion failure still occurs in ≈15% to 30% of patients with large vessel occlusion strokes undergoing MT. We aim to evaluate the safety and efficacy of rescue intracranial stenting for large vessel occlusion stroke after failed MT. Methods: The SAINT (Stenting and Angioplasty in Neurothrombectomy) Study is a retrospective analysis of prospectively collected data from 14 comprehensive stroke centers through January 2015 to December 2020. Patients were included if they had anterior circulation large vessel occlusion stroke due to intracranial internal carotid artery and middle cerebral artery-M1/M2 segments and failed MT. The cohort was divided into 2 groups: rescue intracranial stenting and failed recanalization (modified Thrombolysis in Cerebral Ischemia score 0–1). Propensity score matching was used to balance the 2 groups. The primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale at 90 days. Secondary outcomes included functional independence (90-day modified Rankin Scale score 0–2). Safety measures included symptomatic intracranial hemorrhage and 90-day mortality. Results: A total of 499 patients were included in the analysis. Compared with the failed reperfusion group, rescue intracranial stenting had a favorable shift in the overall modified Rankin Scale score distribution (acOR, 2.31 [95% CI, 1.61–3.32]; P <0.001), higher rates of functional independence (35.1% versus 7%; adjusted odds ratio [aOR], 6.33 [95% CI, 3.14–12.76]; P <0.001), and lower mortality (28% versus 46.5%; aOR, 0.55 [95% CI, 0.31–0.96]; P =0.04) at 90 days. Rates of symptomatic intracerebral hemorrhage were comparable across both groups (7.1% versus 10.2%; aOR, 0.99 [95% CI, 0.42–2.34]; P =0.98). The matched cohort analysis demonstrated similar results. Specifically, rescue intracranial stenting (n=107) had a favorable shift in the overall modified Rankin Scale score distribution (acOR, 3.74 [95% CI, 2.16–6.57]; P <0.001), higher rates of functional independence (34.6% versus 6.5%; aOR, 10.91 [95% CI, 4.11–28.92]; P <0.001), and lower mortality (29.9% versus 43%; aOR, 0.49 [95% CI, 0.25–0.94]; P =0.03) at 90 days with similar rates of symptomatic intracerebral hemorrhage (7.5% versus 11.2%; aOR, 0.87 [95% CI, 0.31–2.42]; P =0.79) compared with patients who failed to reperfuse (n=107). There was no heterogeneity of treatment effect across the prespecified subgroups for improvement in functional outcomes. Conclusions: Acute intracranial stenting appears to be a safe and effective rescue strategy in patients with large vessel occlusion stroke who failed MT. Randomized multicenter trials are warranted.